Loeb S, Dani H. “Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.” Urol Clin North Am. 2017 Nov; 44(4):517-524. PMID: 29107268 Link: https://www.ncbi.nlm.nih.gov/pubmed/29107268
Loeb S, Dani H. “Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.” Urol Clin North Am. 2017 Nov; 44(4):517-524. PMID: 29107268 Link: https://www.ncbi.nlm.nih.gov/pubmed/29107268
Loeb S. “Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients.” Urology Practice. 2017 Jul;4(4):315-321. PMID: 29104903 Link: https://www.ncbi.nlm.nih.gov/pubmed/29104903
Tosoian J and Loeb S. “Radical Retropubic Prostatectomy: Comparison of the Open and Robotic Approaches for Treatment of Prostate Cancer.” Reviews in Urology 2012; 14: 1-8. PMID: 23172996. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502048/
Loeb S. “Prediction of Outcomes After Radical Prostatectomy in Patients Diagnosed with Prostate Cancer of Biopsy Gleason Score ≥8 Via Contemporary Multi (≥12)-Core Prostate Biopsy.” BJU International July 2011; 108: 222. PMID: 21718432. Link: http://www.ncbi.nlm.nih.gov/pubmed/21718432
Loeb S, Ross AE. “Genomic testing for localized prostate cancer: where do we go from here?” Current Opinion in Urology. 2017 Jun 28 epub. PMID: 28661898 Link: https://www.ncbi.nlm.nih.gov/pubmed/28661898
Schaeffer EM, Loeb S, and Walsh PC. “The Case for Open Radical Prostatectomy.” Urological Clinics of North America 2010; 37: 49. Link: http://www.ncbi.nlm.nih.gov/pubmed/20152519
Loeb S and Partin AW. “Open versus minimally invasive radical prostatectomy.” Reviews in Urology, Winter 2010; 12: 20. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859144/
Loeb S, Partin AW, and Schaeffer EM. “Complications of Pelvic Lymphadenectomy: Do the Risks Outweigh the Benefits?” Reviews in Urology, Winter 2010; 12: 20. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859138/
Loeb S, Schaeffer EM, and Epstein JI. “The Vanishing Prostate Cancer Phenomenon.” Urology, January 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20079526
Loeb S and Schaeffer EM. “Optimal Therapy in Localized Prostate Cancer: An Unfolding Story.’” Oncology (Williston Park), September 2009; 23: 843. Link: http://www.ncbi.nlm.nih.gov/pubmed/19839426
Loeb S and Schaeffer EM. “Does Primary Androgen-Deprivation Therapy Improve Survival for Localized Prostate Cancer?” Aging Health 2008; 4: 451. Link: http://www.futuremedicine.com/doi/full/10.2217/1745509X.4.5.451
Loeb S and Catalona WJ. “Open Radical Retropubic Prostatectomy.” Urologic Oncology: Seminars and Original Investigations 2007; 25: 494. Link: http://www.ncbi.nlm.nih.gov/pubmed/18047959
Loeb S and Catalona WJ. “Counterpoint: the case for active treatment.” Journal of the National Comprehensive Cancer Network, August 2007; 5: 699. Link: http://www.ncbi.nlm.nih.gov/pubmed/17692174
Loeb S and Catalona WJ. “Early versus delayed intervention for prostate cancer: the case for early intervention.” Nature Clinical Practice Urology, July 2007; 4: 348. Link: http://www.ncbi.nlm.nih.gov/pubmed/17563779
Lynch J and Loeb S. “The Role of HIFU in Prostate Cancer.” Current Oncology Reports, May 2007; 9: 22. Link: http://www.ncbi.nlm.nih.gov/pubmed/17430694
Loeb S and Nadler RB. “Management of the Complications of External Beam Radiotherapy and Brachytherapy.” Current Urology Reports, May 2006; 7: 200. Link: http://www.ncbi.nlm.nih.gov/pubmed/16630523
Capetown, South Africa. November 8-12, 2016 Lecture topic: Social media in urology Category: Social Media
London, England. 2017 Lecture topic: Social Media Category: Social Media
Lisbon, Portugal. June 28-30, 2017 Lecture topics: Screening for prostate cancer: where do we stand? Category: Prostate Cancer
Hobart, Australia. April 8, 2017 Lecture topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Melbourne, Australia. April 7, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Sydney, Australia. April 5-6, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Adelaide, Australia. April 4, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Brisbane, Australia. April 3, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Hamburgo, Germany. June 23-24, 2017 Lecture Topic: Clinical Use of Markers in Localized Prostate Cancer Category: Prostate Cancer
Toronto, Canada- June 24-27, 2017 Lecture topics: Optimizing Active Surveillance for Prostate Cancer, Serum and Urine Markers to Select Patient for Initial and Repeat Prostate Biopsy Category: Prostate cancer
OncLive: Dr. Loeb on the Impact of Additional Testing for Prostate Cancer (published Oct 11, 2017)
Washington, DC . October 4-7, 2017 Lecture Topic: Women in science panel, poster on crowdfunding in prostate cancer Category: Women in science, Social Media
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E. “Informational needs during active surveillance for prostate cancer: A qualitative study.” Patient Education Counseling 2017 Sep 1 epub. PMID: 28886974 Link: https://www.ncbi.nlm.nih.gov/pubmed/28886974
Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS. “Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions”. European Urology 2017 Aug 22 epub. PMID: 28844371 Link: https://www.ncbi.nlm.nih.gov/pubmed/28844371 We designed a Markov model showing that active surveillance extends life more than… Read More
OncLive: Dr Loeb on the Results of Active Surveillance for Prostate Cancer (published August 2017)
Dani H, Loeb S. “The Role of Prostate Cancer Biomarkers in Undiagnosed Men.” Current Opinion Urology 2017; 27: 210-216. PMID 28212119 Link: https://www.ncbi.nlm.nih.gov/pubmed/28212119
Loeb S, Lilja H, Vickers A. “Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.” Current Opinion in Urology 2016 Jun 3 epub. PMID: 27262138 Link: http://www.ncbi.nlm.nih.gov/pubmed/27262138
Lepor A, Catalona WJ, Loeb S. “The Prostate Health Index: Its Utility in Prostate Cancer Detection. Urologic Clinics North America.” 2016 Feb;43(1):1-6. PMID: 26614024 Link: http://www.ncbi.nlm.nih.gov/pubmed/26614024
Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP. “An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy.” Journal of Urology 2017 Mar 29 epub. PMID: 28363690 Link: https://www.ncbi.nlm.nih.gov/pubmed/28363690 This is an updated American Urological… Read More
Loeb S. “Prostate Biopsy Decisions: One Size Fits All Approach with Total PSA is Out and a Multivariable Approach with the Prostate Health Index is In.” BJU International 2015 June epub. PMID: 26054000. Link: http://www.ncbi.nlm.nih.gov/pubmed/26054000
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA. “Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?” Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390 This study examined effect modification by environmental factors of the association between single nucleotide polymorphisms with prostate… Read More
Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P. “Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.” Journal of Clinical Oncology 2017;35(13):1430-1436. PMID: 28447913. Link: https://www.ncbi.nlm.nih.gov/pubmed/28447913
Loeb S, Ross AE. “Genomic testing for localized prostate cancer: where do we go from here?” Current Opinion in Urology. 2017 Jun 28 epub. PMID: 28661898 Link: https://www.ncbi.nlm.nih.gov/pubmed/28621058